World Wide relies on analytics signals to operate securely and keep research services available. Accept to continue, or leave the site.
Review the Privacy Policy for details about analytics processing.
Prof
University of Nottingham
Showing your local timezone
Schedule
Wednesday, December 6, 2023
1:00 PM Europe/London
Seminar location
No geocoded details are available for this content yet.
Recording provided by the organiser.
Format
Recorded Seminar
Recording
Available
Host
Centre for Human Brain Health University of Birmingham UK
Seminar location
No geocoded details are available for this content yet.
Psychology and neuroscience are increasingly looking to fine-grained analyses of decision-making behaviour, seeking to characterise not just the variation between subjects but also a subject's variability across time. When analysing the behaviour of each subject in a choice task, we ideally want to know not only when the subject has learnt the correct choice rule but also what the subject tried while learning. I introduce a simple but effective Bayesian approach to inferring the probability of different choice strategies at trial resolution. This can be used both for inferring when subjects learn, by tracking the probability of the strategy matching the target rule, and for inferring subjects use of exploratory strategies during learning. Applied to data from rodent and human decision tasks, we find learning occurs earlier and more often than estimated using classical approaches. Around both learning and changes in the rewarded rules the exploratory strategies of win-stay and lose-shift, often considered complementary, are consistently used independently. Indeed, we find the use of lose-shift is strong evidence that animals have latently learnt the salient features of a new rewarded rule. Our approach can be extended to any discrete choice strategy, and its low computational cost is ideally suited for real-time analysis and closed-loop control.
Mark Humphries
Prof
University of Nottingham
neuro
neuro
The development of the iPS cell technology has revolutionized our ability to study development and diseases in defined in vitro cell culture systems. The talk will focus on Rett Syndrome and discuss t
neuro
Pluripotent cells, including embryonic stem (ES) and induced pluripotent stem (iPS) cells, are used to investigate the genetic and epigenetic underpinnings of human diseases such as Parkinson’s, Alzhe